Literature DB >> 12187089

The negative Ca(2+) balance is involved in the stimulation of PTH secretion.

Keitaro Yokoyama1, Shino Kagami, Ichiro Ohkido, Naohiko Kato, Hiroyasu Yamamoto, Takashi Shigematsu, Masaaki Nakayama, Masafumi Fukagawa, Yoshindo Kawaguchi, Tatsuo Hosoya.   

Abstract

The low calcium (Ca(2+)) dialysate have been developed to diminish the risk of hypercalcemia with the administration of active vitamin D and Ca(2+) carbonate as phosphate binder. Today, increasing numbers of hemodialysis (HD) patients have been on the low Ca(2+) dialysate (Ca(2+) = 2.5 mEq/l). However, the clinical consequences of a negative calcium net-balance which may be induced by the use of low Ca dialysate are not well evaluated. In the present study, we explored the effects of low Ca(2+) dialysate on the calcium balance and the PTH secretion. Eighty one chronic HD patients (male/female: 47/34; mean age: 60.2 +/- 1.5 years; mean HD periods: 11.1 +/- 0.8 years) who had been dialyzed with 3.0 mEq/l Ca(2+) dialysate were studied. All patients were transferred to the low Ca dialysate, which actually brought about a negative net-balance in Ca (mean: -94.5 mg) and an increase in serum intact PTH levels (mean: +23.7%: p = 0.03) during a single HD session. However, no changes in serum ionized Ca(2+) were found in spite of negative Ca(2+) balance. One month after change to the low Ca(2+) dialysate (total 12 sessions in each case), serum intact PTH levels increased significantly (186.7 +/- 19.5 vs. 216.2 +/- 21.9 pg/ml: p = 0.01) in spite of the fact that no changes were found in serum ionized Ca(2+), Pi and Mg. This result indicates that the negative Ca(2+) balance during low-Ca(2+) hemodialysis-stimulated PTH secretion, which offset the decrease of serum Ca(2+); a trade-off phenomenon between negative Ca balance and PTH. This suggests that low Ca(2+) dialysate may exaggerate the progression of secondary hyperparathyroidism. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12187089     DOI: 10.1159/000064484

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  4 in total

1.  Effects of low dialysate calcium concentration on health-related quality of life in hemodialysis patients.

Authors:  Yoshinori Taji; Takeshi Morimoto; Shunichi Fukuhara; Tsuguya Fukui; Takashi Kuwahara
Journal:  Clin Exp Nephrol       Date:  2005-06       Impact factor: 2.801

2.  Low calcium dialysate combined with CaCO3 in hyperphosphatemia in hemodialysis patients.

Authors:  Zhuo Gao; Li-DE Lun; Xin-Lun Li
Journal:  Exp Ther Med       Date:  2013-04-17       Impact factor: 2.447

3.  Efficacy and Safety of Evocalcet Evaluated by Dialysate Calcium Concentration in Patients with Secondary Hyperparathyroidism Undergoing Hemodialysis.

Authors:  Takashi Shigematsu; Shinji Asada; Yuichi Endo; Takehisa Kawata; Masafumi Fukagawa; Tadao Akizawa
Journal:  Int J Nephrol Renovasc Dis       Date:  2020-05-12

4.  Influence of dialysate Ca concentrations on the therapeutic effects of etelcalcetide with concomitant drugs in patients with secondary hyperparathyroidism.

Authors:  Takashi Shigematsu; Masafumi Fukagawa; Keitaro Yokoyama; Takashi Akiba; Akifumi Fujii; Atsushi Shinoda; Tadao Akizawa
Journal:  Nephrology (Carlton)       Date:  2019-12-27       Impact factor: 2.506

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.